Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: The children's oncology group

Journal of Clinical Oncology

Volumn 24, Issue 24, 2006, Pages 3844-3851

  Meza, Jane L ^a   Anderson, James ^a   Pappo, Alberto S ^a   Meyer, William H ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; VINCRISTINE; ANTINEOPLASTIC AGENT; IFOSFAMIDE;

ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CHILD; DEMOGRAPHY; FEMALE; HISTOLOGY; HUMAN; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; RHABDOMYOSARCOMA; TREATMENT OUTCOME; UNDIFFERENTIATED CARCINOMA; ADOLESCENT; CLINICAL TRIAL; DISEASE FREE SURVIVAL; DRUG ADMINISTRATION; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MULTICENTER STUDY; PATHOLOGY; PREDICTION AND FORECASTING; PRESCHOOL CHILD; RISK ASSESSMENT; RISK FACTOR; SURVIVAL;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DISEASE-FREE SURVIVAL; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; HUMANS; IFOSFAMIDE; INFANT; INFUSIONS, INTRAVENOUS; MALE; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RHABDOMYOSARCOMA; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINCRISTINE;

EID: 33748474046     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.3801     Document Type: Article

References (16)

1. Crist W, Kun L: Common solid tumors of childhood. N Engl J Med 324:461-471, 1991
2. Pappo AS, Shapiro DN, Crist WM, et al: Biology and therapy of pediatric rhabdomyosarcoma. J Clin Oncol 13:2123-2139, 1995
3. Crist WM, Garnsey L, Beltangady MS, et al: Prognosis in children with rhabdomyosarcoma: A report of the Intergroup Rhabdomyosarcoma Studies I and II. J Clin Oncol 8:443-452, 1990
4. Lawrence W Jr, Anderson JR, Gehan EA, et al: Pretreatment TNM staging of childhood rhabdomyosarcoma: A report of the Intergroup Rhabdomyosarcoma Study Group. Cancer 80:1165-1170, 1997
5. Maurer HM, Beltangady M, Gehan EA, et al: The Intergroup Rhabdomyosarcoma Study: I. A final report. Cancer 61:209-220, 1988
6. Crist W, Gehan EA, Ragab AH, et al: The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 13:610-630, 1995
7. Crist WM, Anderson JR, Meza JL, et al: Intergroup Rhabdomyosarcoma Study-IV: Results for patients with non-metastatic disease. J Clin Oncol 19:3091-3102, 2001
8. Pappo AS, Meza JL, Donaldson SS, et al: Treatment of localized non-orbital non-parameningeal head and neck rhabdomyosarcoma: Lessons learned from Intergroup Rhabdomyosarcoma Studies III and IV. J Clin Oncol 21:638-645, 2003
9. Wiener ES, Anderson JR, Ojimba JI, et al: Controversies in the management of paratesticular rhabdomyosarcoma: Is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma? Semin Pediatr Surg 10:146-152, 2001
10. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
11. Simon R, Wittes RE: Methodologic guidelines for reports of clinical trials. Cancer Treat Rep 69:1-3, 1985
12. Cox DR: Regression models and life tables. J R Stat Soc B 34:187-220, 1972
13. Raney RB, Anderson JR, Barr FC, et al: Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: A selective review of the Intergroup Rhabdomyosarcoma Study Group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J Pediatr Hematol Oncol 23:215-220, 2001
14. Flamant F, Rodary C, Rey A, et al: Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence: Results of the second study of the International Society of Paediatric Oncology - MMT84. Eur J Cancer 34:1050-1062, 1998
15. Koscielniak E, Harms D, Henze G, et al: Results of treatment for soft tissue sarcoma in childhood and adolescence: A final report of the German Cooperative Soft Tissue Sarcoma Study, CWS-86. J Clin Oncol 17:3706-3719, 1999
16. Breitfeld PP, Lyden E, Raney RB, et al: Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: A report from the Intergroup Rhabdomyosarcoma Study Group. J Pediatr Hematol Oncol 23:334-337, 2001